QIAGEN NV (QIA MU) stock market data APIs
€36.7656
0(0%)
as of September 16, 2026
Try our APIs with
free plan!
QIAGEN NV Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for QIA.MU.
Prev. Close
36.7656
Open
36.7656
High
36.7656
Low
36.7656
52 wk Range
27.9026-46.7752
Market Cap
10 941 M
EPS
0.55
Dividends (Yield)
0
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get QIAGEN NV data using free add-ons & libraries
Get QIAGEN NV Fundamental Data
QIAGEN NV Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-07
- EPS/Forecast: 0.5
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
QIAGEN NV News
New
Transcriptome Sequencing Market - Global Forecast to 2035; Bulk RNA-Seq Maintains Its Technology Market Lead
Company Logo The global transcriptome sequencing market is projected to reach $11.8 billion by 2035, growing at a 7.3% CAGR from 2025 to 2035. Growth is driven by falling sequencing costs, precision ...
Qiagen (QGEN) Beat Q2 Estimates And Reaffirmed Outlook, Is It Still Below Fair Value?
Qiagen (QGEN) has drawn fresh attention after Q2 2026 adjusted earnings and net sales came in above consensus, even as estimates had recently drifted lower, and management reaffirmed its full year out...
How Qiagen’s New Automation Platform, CEO Transition and Q2 Beat Will Impact Qiagen (QGEN) Investors
In late August 2026, Qiagen launched QIAsymphony Connect, an IVD-compliant automated nucleic acid extraction platform with FDA and EUDAMED listings, while also announcing a CEO transition to Jon Pratt...
Qiagen (QGEN) Up 5.1% Since Last Earnings Report: Can It Continue?
A month has gone by since the last earnings report for Qiagen (QGEN). Shares have added about 5.1% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the recent p...
Get QIAGEN NV fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
